Aller au contenu principal
Profil bibliographique

Chakkarin Burudpakdee

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

78Publications signalées
694Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Health Systems, Economic Evaluations, Quality of LifeDiabetes Treatment and ManagementMedication Adherence and ComplianceEconomic and Financial Impacts of CancerAsthma and respiratory diseases

Les publications récentes

Accès ouvert 2023 article OpenAlex

The Relative Value of Anti-Obesity Medications Compared to Similar Therapies

Nina Kim, Joaquin J. Estrada, Isabella Chow, Aleksandrina Ruseva et autres

Purpose: To demonstrate a need for improved health insurance coverage for anti-obesity medications (AOMs) by comparing clinical and economic benefits of obesity treatments to covered medications for selected therapeutic areas. Methods: Using a grey literature search, we identified and prioritized therapeutic areas …

us (code pays fourni par la source)

12 citations ClinicoEconomics and Outcomes Research
Accès ouvert 2022 article OpenAlex

Development of an Assessment Tool for Completion by Patients with Overweight or Obesity

Nina Kim, T. Michelle Brown, Chakkarin Burudpakdee, Chisom Kanu et autres

INTRODUCTION: Discussions of weight-management strategies between patients and healthcare providers can yield positive outcomes for people with overweight or obesity. Nonetheless, people with overweight or obesity encounter communication challenges and other barriers to pursuing effective weight-management strategies with their healthcare providers. The …

us, no (code pays fourni par la source)

0 citations Advances in Therapy
Accès ouvert 2022 article OpenAlex

Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States

Nina Kim, Jessie J.J. Wang, Chakkarin Burudpakdee, Yan Song et autres

BACKGROUND: The rising prevalence and associated public health burden of obesity has led to advancements in pharmaceuticals for weight management. Semaglutide 2.4 mg, an anti-obesity medication (AOM) recently approved by the US Food and Drug Administration, has demonstrated clinically relevant weight loss …

us (code pays fourni par la source)

81 citations Journal of Managed Care & Specialty Pharmacy
2022 article OpenAlex

Real-world HIV diagnostic testing patterns in the United States

Chakkarin Burudpakdee

OBJECTIVES: To understand real-world implementation of the updated CDC HIV diagnostic testing algorithm. STUDY DESIGN: Retrospective database analysis. METHODS: Using data from Quest Diagnostics, we identified patients with at least 1 HIV-1/HIV-2 antibody differentiation test (BioRad Geenius HIV 1/2 Supplemental Assay [Geenius]) …

2 citations The American Journal of Managed Care
Accès ouvert 2022 article OpenAlex

Penile surgery for patients with Peyronie’s disease initially treated with collagenase clostridium histolyticum or surgery: a claims database analysis

Landon W Trost, Huan Huang, Xu Han, Chakkarin Burudpakdee et autres

Collagenase clostridium histolyticum (CCH) is an injectable therapy targeting collagen present in penile plaques in Peyronie's disease (PD). Data comparing CCH to penile surgery are limited, and long-term therapeutic outcomes are unknown. This retrospective analysis used a US claims database (January 2014-June …

us (code pays fourni par la source)

6 citations International Journal of Impotence Research
Accès ouvert 2021 article OpenAlex

The Incidence, Prevalence, and Associated Costs of Anemia, Malignancy, Venous Thromboembolism, Major Adverse Cardiovascular Events, and Infections in Rheumatoid Arthritis Patients by Treatment History in the United States

Robin K. Dore, Jenya Antonova, Chakkarin Burudpakdee, Lawrence Chang et autres

OBJECTIVE: Comorbidities in rheumatoid arthritis (RA) can influence treatment selection, impact treatment persistency, and increase health care costs. This study assessed the magnitude of comorbidity burden via epidemiology (incidence and prevalence) and associated costs of select comorbidities in RA patients: anemia, malignancy, …

us (code pays fourni par la source)

9 citations ACR Open Rheumatology
Accès ouvert 2021 article OpenAlex

Effect of a Patient Support Program for Idiopathic Pulmonary Fibrosis Patients on Medication Persistence: A Retrospective Database Analysis

Aimee M. Near, Chakkarin Burudpakdee, Shilpa Viswanathan, Shuchita Kaila

INTRODUCTION: In 2015, Boehringer Ingelheim (BI) created a support program for patients with idiopathic pulmonary fibrosis (IPF) treated with nintedanib, to help patients obtain their prescription, learn about their disease and medication, and provide support in the management of their IPF. The …

us (code pays fourni par la source)

9 citations Advances in Therapy
Accès ouvert 2021 article OpenAlex

Treatment Patterns and Healthcare Outcomes with Collagenase Clostridium Histolyticum vs Surgery in Peyronie's Disease: A Retrospective Claims Database Analysis

Landon W Trost, Huan Huang, Xu Han, Chakkarin Burudpakdee et autres

INTRODUCTION: Treatments for Peyronie's disease (PD) include surgical management and collagenase clostridium histolyticum (CCH). AIMS: To evaluate PD treatment trends after CCH approval and compare clinical outcomes in CCH- and surgery-treated cohorts. METHODS: Patients newly diagnosed with PD between January 2011 and …

us (code pays fourni par la source)

11 citations Sexual Medicine
Accès ouvert 2020 article OpenAlex

The Impact of a Forced Non-Medical Switch of Inhaled Respiratory Medication Among Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Patient Survey on Experience with Switch, Therapy Satisfaction, and Disease Control

Ileen Gilbert, Keiko Wada, Chakkarin Burudpakdee, Chirag Ghai et autres

Purpose: Budesonide/formoterol pressurized metered-dose inhaler (pMDI) was removed from a Medicare Part D formulary, and patients switched to fluticasone-based dry powder inhaler (DPI) therapies. This study describes the experience, satisfaction, and disease control among patients with asthma or chronic obstructive pulmonary disease …

us (code pays fourni par la source)

13 citations Patient Preference and Adherence
Accès ouvert 2020 article OpenAlex

The Impact of a Forced Non-Medical Switch of Inhaled Respiratory Medication Among Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Patient Survey on Experience with Switch, Therapy Satisfaction, and Disease Control

I Gilbert, K Wada, Chakkarin Burudpakdee, C Ghai et autres

Ileen Gilbert,1 Keiko Wada,2 Chakkarin Burudpakdee,2 Chirag Ghai,2 Laren Tan3 1AstraZeneca, Wilmington, DE, USA; 2IQVIA, Falls Church, VA, USA; 3Loma Linda University Health, Department of Medicine, Division of Pulmonary, Critical Care, Hyperbaric, Allergy and Sleep Medicine, Loma Linda, CA, USACorrespondence: Ileen Gilbert …

2 citations DOAJ (DOAJ: Directory of Open Access Journals)

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.